MATTO seminars


Dear MATTO members,

You are invited to a MATTO seminar on Wednesday, October 11, 2017:

“Resolving Inventorship & Royalty Distribution Disputes.”

Please note that our seminar will be in a slightly different location just a short walk from our usual meeting room: Cloud City Room, 14th floor, CIC, 101 Main Street, Cambridge.

This seminar will focus on the resolution of inventorship disputes and royalty distribution disputes and the presenters will orient the discussion around specific, real-world case studies. As a starting point, the patent attorneys on the panel will provide an overview of inventorship determination according to US patent law and laws of other key jurisdictions. Inventorship disputes can be complicated, messy and expensive to resolve. The same applies to royalty distribution disputes, of which there have been a few high profiles ones recently. This seminar is intended to provide the technology transfer professional with additional tools and experience to effectively manage such disputes -and ideally avoid them all together.


  • Melissa Hunter-Ensor, Partner, Greenberg Traurig, LLP
  • Fangli Chen, Partner, Proskauer Rose LLP

Moderator: John Cosmopoulos, Senior Associate Director, Office for Technology Transfer & Industry Collaboration, Tufts University

Seminar Organizer: Robert Benson, Principal, South Shaker Associates


The seminar is free but you have to register on this link 

Refreshments and Networking at 3:30 – 4:00 PM. 

Speaker Bios:   

John Cosmopoulos 

John Cosmopoulos is the Senior Associate Director in the Office for Technology Transfer & Industry Collaboration at Tufts University where he manages the licensing team and is the main contact for the Schools of Medicine and Dental Medicine. He has 20 years of diverse experience in technology transfer and a true passion for supporting the development and translation of early-stage innovations into successful commercial products and services that will benefit the public and return value to the inventors and the institution. He holds a biology undergraduate degree, M.Sc. degree in molecular biology, a MBA degree from Queen’s University in Canada, and the Certified Licensing Professional (CLP) designation.

Melissa Hunter-Ensor 

Melissa Hunter-Ensor, Ph.D. is a partner in the Boston office of Greenberg Traurig, LLP.  She has a strong scientific background that includes graduate work at the University of Pennsylvania, which resulted in a first-author Cell paper, and post-doctoral training at MIT in the laboratory of Nobel laureate Dr. H. Robert Horvitz.  Dr. Hunter-Ensor works with clients including leading universities, research institutes, start-up companies, and international pharmaceutical companies to develop and manage complex IP portfolios.  Her practice includes intellectual property prosecution, post-grant challenges, licensing, as well as counseling investors and companies in assessing intellectual property assets in connection with mergers and acquisitions.

Fangli Chen

Dr. Fangli Chen is a partner in the Litigation Department and vice chair of the Life Sciences Patent practice at Proskauer Rose. Dr. Chen represents all types of companies in the biotech and pharmaceutical industries, and has deep scientific expertise and a strong business sense. She effectively identifies and transforms technological developments into valuable intellectual property assets for her clients and specializes in the strategic development of complex IP portfolios for companies that align with their business goals. The primary focus of her practice is intellectual property prosecution, which includes strategic development of complex patent portfolios for companies, universities and research institutions. She prepares and prosecutes patent applications in the fields of biochemistry, molecular and cell biology, immunology, biochemical and molecular diagnostics, pharmaceuticals, microbiology, molecular genetics, pharmacogenomics, recombinant technologies, enzyme replacement therapy, messenger RNA therapy, gene therapy, bioinformatics, drug discovery, medical devices and chemistry; performs due diligence investigations, and provides freedom-to-operate studies, non-infringement and invalidity analysis.